NaveenLPereiraMD

PubMed

• 35 citations
  Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation
  Rabea Asleh, Alfredo L. Clavell, Naveen L. Pereira, Byron H. Smith, Alexandros Briasoulis
  Journal of the American College of Cardiology. 2019-06-04
• 20 citations
  Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias.
  Piero Gentile, Marco Merlo, Giovanni Peretto, Enrico Ammirati, Simone Sala
  European Journal of Heart Failure. 2021-07-01
• 116 citations
  Myocarditis in Clinical Practice
  Gianfranco Sinagra, Marco Anzini, Naveen L. Pereira, Rossana Bussani, Gherardo Finocchiaro
  Mayo Clinic Proceedings. 2016-09-01

Journal Articles

• Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention  
  Naveen L Pereira, Verghese Mathew, Charles Cagin, Amir Lerman, Charanjit Rihal, JAMA
• Genotype-guided dosing of Vitamin K antagonists  
  Pereira NL, Rihal CS, Weinshilboum RM, N Engl J Med., 5/1/2014
• The possible impact of lack of ethnic and geographical diversity on the association of MTHFR mutations, homocysteine levels and heart disease outcomes  
  Pereira NL, Ball-Berry JE, Green El, Heart, 12/4/2013
• CD3 monitoring and thymoglobulin therapy in cardiac transplantation: clinical outcomes and pharmacoeconomic implications  
  Uber WE, Uber LA, VanBakel AB, Crumbley AJ 3rd, Pereira NL, Ikonomidis JS, Feldman DS, Transplant Proc., 12/1/2004
• Reversible left ventricular dysfunction simulating a myocardial infarction after pericardiectomy  
  * Wood DE, Crumbley AJ, Pereira NL, Heart, 8/1/2002
• Cardiac amyloidosis  
  * Kingman A, Pereira NL, Internal Medicine, 1/1/2002
• Cardiac amyloidosis  
  *Kingman A, Pereira NL, J S C Med Assoc., 5/1/2001
• Join now to see all

Books/Book Chapters

• Heart Failure: A Companion to Braunwald's Heart Disease 
  Chapter: Heart failure as a consequence of viral and nonviral myocarditis. 
  Page 465 - 476Pereira N, Cooper LT JrEditors: Mann DL.Elsevier/Saunders, St. Louis, MOEdition 2nd,2011
• Mayo Clinic Internal Medicine Board Review 
  Chapter: Heart failure and cardiomyopathies. 
  Page 97 - 110Karon BL, Pereira NLEditors: Ghosh AK, et al..Mayo Clinic Scientific Press, Rochester, MNEdition 9th,2010
• Heart Transplantation 
  Chapter: Clinical Immunosuppressive Strategies. 
  Pereira NL, Dec GWEditors: Mudge GH, Jarcho JA, Mitchell RN.W.B. SaundersEdition 1st,2002
• Cardiology 
  Chapter: Restrictive/infiltrative cardiomyopathy. 
  Pereira NL, Dec GWEditors: Crawford M, Dimarco J.Mosby International2001
• Care of the elderly: clinical aspects of aging 
  Chapter: Valvular disease in the elderly. 
  Pereira NL, Khan AHEditors: Reichel W.Williams & Wilkins1997
• Join now to see all

Abstracts/Posters

• Genetic Association Study of Circulating Galectin-3 in the General Community Identifies a Variant Associated with Myocardial Infaction. (Poster)
  Pereira NL, American Heart Association Scientific Sessions 2014, Chicago, IL, 11/1/2014
• Role of vad therapy for patients with restrictive cardiomyopathy: improving outcomes for a lethal disease.
  Grupper A, Joyce LD, Stulak JM, Schettle SD, Gerber Y, Topilsky Y, Pereira NL, Edwards BS, Daly RC, Park SJ, Kushwaha SS, J Heart Lung Transplant, 4/1/2014
• Time to achieving therapeutic international normalized ratio increases hospital length of stay in cardiac valve surgical patients.
  Pereira N, Pathak J, Thalji N, Arendt C, Mehta R, Scott CG, Bailey K, Daly R, J Am Coll Cardiol, 1/1/2014
• Genetic association study of circulating Galectin-3 in the general community identifies a variant associated with myocardial infarction.
  Pereira N, Scott C, Jenkins G, Robinson D, Tosakulwong N, Burnett J, Weinshilboum R, Redfield M, Circulation, 1/1/2014
• Genetic association study of circulating nt-proanp in the general community identifies a novel gene cluster associated with stroke.
  Pereira NL, Tosakulwong N, Scott CG, Jenkins GD, Prodduturi N, Redfield MM, Olson TM, Rodeheffer RJ, Weinshilboum RM, Burnett JC, Circulation, 11/26/2013
• Genetic variation in the natriuretic peptide clearance receptor is associated with diastolic dysfunction in the general community.
  Pereira NL, Redfield MM, Scott CG, Tosakulwong N, Olson TM, Rodeheffer R, Burnett J, Circulation, 11/26/2013
• Exercise capacity and peak VO2 improve modestly following left ventricular assist device implantation.
  * Dunlay SM, Allison TG, Pereira NL, J Card Fail., 8/1/2013
• Thiopurine s-methyltranferase heterozygote heart transplant recipients treated with azathioprine are at an increased risk for rejection.
  * Liang J, Geske J, Boilson B, Kremers W, Weinshilboum R, Pereira N, Eur Heart J., 8/1/2013
• Hemodynamic assessment in patients on chronic continuous flow left ventricular assist device support.
  Hasin T, Schettle SD, Nativi-Nicolau J, Park SJ, Borlaug BA, Pereira NL, Edwards BS, Clavell AL, Joyce LD, Stulak JM, Daly RC, Kushwaha SS, J Heart Lung Transplant, 4/1/2013
• Changes in left ventricular ejection fraction following implantation of left ventricular assist device as destination therapy.
  Dunlay SM, Park SJ, Chandrasekaran K, Choi JO, Pereira NL, Joyce LD, Daly RC, Stulak JM, Kushwaha SS, J Heart Lung Transplant, 4/1/2013
• Long-term renoprotective effect of sirolimus-based calcineurin inhibitor-free immunosuppression after cardiac transplantation.
  Choi JO, Riaz T, Boilson BA, Schirger JA, Pereira NL, Clavell AL, Frantz RP, Daly RC, Edwards BS, Park SJ, Rodeheffer RJ, Kushwaha SS, J Heart Lung Transplant, 4/1/2013
• Pharmacogenetics of azathioprine: efficacy and toxicity in thiopurine-S-methyltransferase heterozygotes following cardiac transplant.
  * Liang JJ, Geske JR, Boilson BA, Kremers WK, Pereira NL, J Card Fail., 8/1/2012
• Cardiac allograft remodeling is associated with increased inflammatory burden of coronary atherosclerotic plague.
  * Raichlin E, Matsuo Y, Kushwaha SS, Clavell AL, Frantz RP, Rodeheffer RJ, Edwards BS, Boilson BA, Schirger JA, Lerman A, Pereira NL, J Heart Lung Transplant, 4/1/2012
• Combined heart and liver transplant attenuates cardiac allograft vasculopathy with decreased coronary related cardiac events compared to isolated heart transplantation.
  Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman ..., J Heart Lung Transplant, 4/1/2012
• Late decline in renal function following implantation of continuous flow left ventricular assist devices.
  Hasin T, Topilsky Y, Liu M, Li Z, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS, J Heart Lung Transplant, 4/1/2012
• Readmissions following implantation of axial flow left ventricular assist devices.
  Hasin T, Marmor Y, Topilsky Y, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Richard D, Park SJ, Kushwaha SS, J Heart Lung Transplant, 4/1/2012
• Impaired 6 minute walk test after continuos axial flow left ventricular device implantation is associated with reduced survival.
  * Hasin T, Topilsky Y, Kremers W, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Daly R, Kushwaha SS, Park SJ, Pereira NL, J Heart Lung Transplant, 4/1/2012
• Improvement in functional capacity after left ventricular assist device therapy can be limited by preoperative comorbidities.
  Kiernan MS, Pham DT, Kapur NK, Pereira NL, Sundareswaran KS, Stueber M, Farrar DJ, DeNofrio D, Rogers JG, J Heart Lung Transplant, 4/1/2012
• Allosensitization associated with continuous axial flow left ventricular assist device implantation does not affect outcomes after heart transplantation.
  * Shankar N, Geske J, Gandhi M, Timmons M, Boilson B, Schirger J, Clavell A, Frantz R, Rodeheffer R, Daly R, Joyce L, Edwards B, Kremers W, Kushwaha SK, Park S, Pereir..., J Heart Lung Transplant, 4/1/2012
• Sirolimus based immunosuppression attenuates cardiac allograft vasculopathy progression by decreasing fibrotic component of coronary atherosclerotic plaque.
  Raichlin E, Matsuo Y, Pereira NL, Edwards BS, Frantz RP, Clavell AL, Rodeheffer RJ, Boilson BA, Schirger JA, Lerman A, Kushwaha SS, J Heart Lung Transplant, 4/1/2012
• A Novel Polymorphism Arg146 of the Natriuretic Peptide Receptor-3 Gene Results in a Significant Reduction in Protein Expression Due to Accelerated Degradation.
  Pereira NL, Dong L, Pelleymounter L, Moon I, Stilling G, Eckloff B, Wieben E, Yee V, Redfield M, Burnett J, Weinshilboum R, Circulation, 4/1/2012
• Hyperbilirubinemia after axial flow left ventricular assist device implantation is associated with increased mortality.
  Hasin T, Kamath P, Kremers W, Topilsky Y, Schirger J, Boilson B, Clavell A, Rodeheffer R, Frantz R, Edwards B, Pereira N, Joyce L, Daly R, Park S, Kushwaha S, J Am Coll Cardiol., 3/27/2012
• Late decline in renal function following implantation of continuous flow left ventricular assist devices.
  Hasin T, Topilsky Y, Schirger J, Li Z, Boilson B, Clavell A, Rodeheffer R, Frantz R, Edwards B, Pereira N, Joyce L, Daly R, Park S, Kushwaha S, J Am Coll Cardiol., 3/27/2012
• New Mechanisms from Experimental Models. (Poster)
  Pereira NL, ACC 61st Annual Scientific Session and ACC-i2 with TCT, Chicago, IL, 3/1/2012
• Donor specific alloantibodies to HLA II antigens result in accelerated cardiac allograft vasculopathy assessed by 3d volumetric ivus.
  * Topilsky Y, Gandhi MJ, Hasin T, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Park SJ, Daly RC, Lerman A, Kushwaha ..., Circulation, 11/22/2011
• Join now to see all

Lectures

• Cardiovascular Pharmacogenomics 2014: Right Drug for the Right Patient 
  Chicago, IL - 11/1/2014
• Antiplatelet Therapy and Pharmacogenomics for the Clinician 
  Vina del Mar, Chile - 8/1/2014
• Cardiovascular Pharmacogenomics: Giving the Right Drug to the Right Patient 
  Ottawa, Canada - 5/1/2014
• Nonischemic Cardiomyopathy: Anatomical Aspects with Clinical Perspectives 
  Stellenbosch, South Africa - 4/1/2014
• Tailoring Cardiovascular Drugs Based on Your Genes 
  Rochester, MN - 4/1/2014
• Time to Achieving Therapeutic International Normalized Ratio Increases Hospital Length of Stay in Cardiac Valve Surgical Patients 
  Washington, DC - 3/1/2014
• Keynote Lecture: TAILOR PCI and Antiplatelet Agents 
  Seoul, South Korea - 1/1/2014
• Right Ventricular Failure in LVAD Patients 
  Seoul, South Korea - 1/1/2014
• ACS, NSTEMI, and STEMI-Illustrative Case Review 
  Las Vegas, NV - 11/1/2013
• Chronic CAD: Illustrative Case Reviews 
  Las Vegas, NV - 11/1/2013
• Genetic Variation in the Natriuretic Peptide Clearance Receptor is Associated with Diastolic Dysfunction in the General Community 
  Dallas, TX - 11/1/2013
• Genetic Association Study of Circulating NT-proANP in the General Community Identifies a Novel Gene Cluster Associated with Stroke 
  Dallas, TX - 11/1/2013
• Nonischemic Cardiomyopathy 
  Sioux Falls, SD - 10/1/2013
• Diastolic Heart Failure 
  Sioux Falls, SD - 10/1/2013
• Clopidogrel Pharmacogenetics: How Can We Impact Clinical Practice? 
  Toronto, Ontario, Canada - 10/1/2013
• Exercise Capacity and Peak VO2 Improve Modestly Following Left Ventricular Assist Device Implantation 
  Orlando, FL - 9/1/2013
• Left Ventricular Assist Devices: An Update 
  Dalian, China - 8/1/2013
• Advanced Heart Failure: Current Strategies and Future Directions 
  Dalian, China - 8/1/2013
• Thiopurine S-Methyltransferase Heterozygote Heart Transplant Recipients Treated with Azathioprine are at an Increased Risk for Rejection 
  Amsterdam, Netherlands - 8/1/2013
• Coronary Thrombus Post PCI: Should we TAILOR our ‘Genes’? 
  Rochester, MN - 2/1/2013
• Controversies and Challenges in the Management of Ischemic Failure/Vascular Diseases 
  Dubai, United Arab Emirates - 1/1/2013
• 52-year-old Male Patient with New Onset Systolic Heart Failure 
  Dubai, United Arab Emirates - 1/1/2013
• 32-year-old Female with Post Partum Cardiomyopathy 
  Dubai, United Arab Emirates - 1/1/2013
• Controversies and Challenges in Heart Failure Management: Special Populations 
  Dubai, United Arab Emirates - 1/1/2013
• Advanced Heart Failure with Worsening Renal Function: Cardio-Renal Syndrome 
  Dubai, United Arab Emirates - 1/1/2013
• Join now to see all

Other

• COAG and EU-PACT: The pharmacogenetics of warfarin dosing. 
  Pereira NL, Medscape
  12/5/2013
• Ventricular Assist Device. (Television Interview) 
  Pereira NL, WCSC Channel 5, CBS Affiliate
  11/1/2004
• CHF - Treatment Options. (Television Interview) 
  Pereira NL
  WCSC Channel 5, CBS Affiliate - 6/1/2004
• ACE inhibitors underutilized for congestive heart failure. 
  Pereira NL, Quality Partners
  1/1/2004
• BNP Diagnostic Marker for CHF. (Television Interview) 
  Pereira NL, WCSC Channel 5, CBS Affiliate
  1/1/2003
• Join now to see all